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Ventricular tachycardia (VT) is considered as the main cause for syncope
after myocardial infarction (MI). Multiple other causes have been reported.
When left ventricular ejection fraction (LVEF) is low (35 %), the implantation
of a defibrillator (ICD) is recommended. The mortality of these patients (pts)
remains relatively high. The purpose of study was to evaluate the main causes
implicated in syncope after MI and the clinical factors associated with the
diagnosis.
Methods: 363 pts, 307 men, 56 women, consecutively admitted for syn-
cope and history of MI (> 1 month), without VT underwent echocardiography,
Holter monitoring, head-up tilt-test, exercise testing, signal-averaged ECG,
electrophysiological study (EPS) and evaluation of coronary status. They were
followed 4±2 years.
Results: The presumed cause of syncope was attributed after EPS to a ven-
tricular arrhythmia in 151 pts (monomorphic VT 88, ventricular flutter or
fibrillation (VF) 63), to a supraventricular tachyarrhythmia (SVT) in 39 pts, to
conduction disturbances in 24 pts; 57 pts had several electrophysiological
abnormalities: 26 had inducible VT or SVT and coronary ischemia; hypervag-
otonia was noted in 8 pts with induced VT or SVT. In the case of negative
EPS, coronary ischemia alone was identified in 41 pts, hypervagotonia in
27pts. All studies were negative and syncope remains unexplained in 86 pts
(24 %), mainly women (p<0.001)(27 % vs 20%***). Male gender (90 % vs
80 %**), a longer QRS duration (139±31 vs 115±28 ms**), a lower LVEF
(36±11.5 vs 46±12 %***) and grade IVa,b of Lown on Holter ECG (53 vs
31.5 %***) were associated with VT induction. LVEF < 40 % and VT/VF
induction were predictors of cardiac mortality, VT predictor of sudden death,
low LVEF and advanced age predictors of death by heart failure. 
Conclusions: Several causes were frequently implicated; therefore com-
plete evaluation remains necessary. Coronary ischemia was present in 18 % of
patients with syncope after myocardial infarction; it was the sole cause in 11%
of our population. Syncope remained unexplained more frequently in women
than in men. Hypervagotonia explains syncope in only 8 % of our population.
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Introduction: Acute coronary syndrome (ACS) may be complicated by
acute or subacute, major, noncardiac conditions. Few data are available
regarding their exact prevalence and prognostic value. 
Purpose: We sought to determine the prevalence of major noncardiac condi-
tions in ACS patients and their prognostic value.
Methods: A total of 1936 patients consecutively admitted with ACS
were reviewed. We considered as acute or subacute, major, noncardiac con-
ditions the following pathologies: pneumonia, decompensate chronic
obstructive pulmonary disease, sepsis, stroke, anaemia, severe deterioration
of renal function and active malignancy. We compared patients with at least
one noncardiac condition to the others. Primary end points were in-hospital
and 6-month mortality.
Results: Two hundred and three patients (10.5%) had at least one acute or
subacute, major, noncardiac condition. Patients with a noncardiac condition were
older, more frequently women and more often had diabetes mellitus, arterial
hypertension and renal insufficiency (p <0.05). At admission, they more often
presented with Killip class higher than one (p <0.05) but there were no differ-
ences regarding ACS presentation. They were less likely to be medicated with
clopidogrel, β-blocker and statin (p <0.05) and to undergo invasive strategies
and coronary revascularization (p <0.05). They had higher in-hospital and six-
month mortality (19.6% vs 3.3% and 35.1% vs 7.7%, respectively; p <0.001).
Multivariate analysis confirmed the presence of a noncardiac condition as an
independent predictor of in-hospital mortality (OR=3,88; 95%CI=1,87-8,03) and
six-month mortality (OR=2,56; 95%CI=1,42-4,42).
Conclusions: The presence of an acute or subacute, major, noncardiac con-
dition was a powerful predictor of in-hospital and six-month mortality. Our
results outline the importance of treating or preventing noncardiac conditions
that negatively influence the prognosis of ACS patients.
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Aim: We sought to determine the incidence and type of major bleeding in
moderate-to-high risk acute coronary syndromes (ACS) treated with intense
antiplatelet therapy and systematic invasive strategy using predominantly the
radial approach. We also examined whether these bleedings has an impact on
mortality after multivariable adjustment. 
Methods: In the multicenter randomized ABOARD study, 352 patients
with acute coronary syndromes without ST-segment elevation were random-
ized for a “primary PCI” strategy or a strategy of intervention deferred to the
next working day. No difference was observed in clinical outcomes between
the two groups. Major bleeding complications (STEEPLE definitions) were
correlated to 1 month mortality. 
Results: Patients were treated by intense antiplatelet therapy: with a mean
660 mg (±268) loading of clopidogrel and 111 mg (±40) maintenance dose
while 99% of the PCI patients receive abciximab the radial approach was pre-
dominant (84%). 
During the first 30 days major bleeding complications occurred in 19
patients (5.4%) with transfusion in 16 patients (4.5%). Occurrence of major
bleeding did not differ between immediate and delayed intervention. The most
frequent overt bleeding complications were from the gastrointestinal tract. The
composite of GI bleeding and occult bleeding (loss of Hb of >3 g/dL) repre-
sented n=11 (57.9%) of all major bleeding complications. Major bleeding was
associated with a significantly higher peak of creatinine during hospitalization
170.16 µmol/L ± 169.34 vs. 97.05 µmol/L ± 56.96 (p=0.005) and a higher
mortality rate 26.3% vs. 0.6%. After adjustment for all baseline characteristics,
major bleeding was independently associated with an impressive increased
hazard of death during the first 30 days (Odd ratio 75.7; 95% CI, 11.3 to
505.3; p<0.0001).
Conclusion: In a population of radial catheterization for NSTEACS, GI
bleeding is the most frequent bleeding complication. Despite the reduction of
access site bleeding, major bleeding still remains a major independent pre-
dictor of mortality. 
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